Leavitt Equity Partners – a value-added healthcare-focused private equity firm – recently announced the closing of its third fund, Leavitt Equity Partners III (LEP III). And LEP III raised over $180 million, surpassing the investment firm’s initial target of $150 million.
As with predecessor funds, LEP III is seeking to invest in lower middle-market healthcare companies focusing on services, care models, and technologies that bring value to healthcare in the form of lower costs, better quality, and better access.
Launched in 2014 by Michael Leavitt, former United States Secretary of the Department of Health and Human Services, LEP utilizes the healthcare intelligence and broad network of its Principals to help portfolio companies thrive in a complex and ever-changing healthcare system. And LEP manages over $400 million in capital, raised primarily from strategic healthcare partners, including healthcare provider systems, national and regional health insurers, healthcare service providers, healthcare IT companies, pharmaceutical companies, and healthcare executives and entrepreneurs.
Dorsey & Whitney served as legal advisors to Leavitt Equity Partners in the formation of LEP III.
KEY QUOTES:
“We are delighted with the outcome of this fundraise and the strong support from both existing and new investors.”
— Taylor Leavitt, LEP’s Managing Partner and CEO
“We believe our ability to bring deep healthcare policy and strategic expertise enables significant growth potential for our portfolio companies as we look to support a more value-driven healthcare future.”
— Andrew Clark, LEP’s Managing Partner
